CMB 4.76% 40.0¢ cambium bio limited

Ann: Regeneus signs MOU with Kyocera Corporation, page-18

  1. 163 Posts.
    lightbulb Created with Sketch. 3
    gmac55

    "The success of Progenza on this front was recently documented in Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."

    RGS ASX announcement 23/03/2020 specifically does not include "The success of Progenza on this front was recently documented in.."

    Progenza was not used as a treatment or cited in the referenced publication.

    Where did you source that statement?
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
-0.020(4.76%)
Mkt cap ! $5.011M
Open High Low Value Volume
42.0¢ 42.0¢ 40.0¢ $2.069K 5.062K

Buyers (Bids)

No. Vol. Price($)
2 8915 40.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 1910 1
View Market Depth
Last trade - 10.11am 29/07/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.